We also found that the total m6A modification level (Fig. 1C) and KIAA1429 expression (Fig. 1D, E; Fig. S1E) were significantly more up-regulated in the CML-BC group than that in the CML-CP group, indicating that KIAA1429 could be associated with CML progression. This evidence concerns the gene VIRMA and chronic myelogenous leukemia, BCR-ABL1 positive.